Zacks Investment ResearchTue, 02 Jun 2026 16:51:12 GMTNPCE Receives FDA Approval for AI-Powered ECoG Assistant for EpilepsyNPCE+2.56%
Zacks Investment ResearchWed, 27 May 2026 16:00:21 GMTIs NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?NPCE+2.56%
Zacks Investment ResearchWed, 27 May 2026 15:46:06 GMTNPCE Explains How NeuroPace's RNS System Makes MoneyNPCE+2.56%
Zacks Investment ResearchWed, 27 May 2026 15:36:06 GMTNeuroPace NPCE and the Next Wave of AI-Driven Epilepsy CareNPCE+2.56%
Zacks Investment ResearchWed, 13 May 2026 17:25:42 GMTNPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook RaisedNPCE+2.56%
Seeking AlphaWed, 13 May 2026 02:10:49 GMTNeuroPace, Inc. (NPCE) Q1 2026 Earnings Call TranscriptNPCE+2.56%
Zacks Investment ResearchTue, 12 May 2026 22:40:17 GMTNeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue EstimatesNPCE+2.56%
Zacks Investment ResearchThu, 07 May 2026 14:36:09 GMTNeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?NPCE+2.56%
Zacks Investment ResearchThu, 02 Apr 2026 16:31:05 GMTNeuroPace (NPCE) Up 0.9% Since Last Earnings Report: Can It Continue?NPCE+2.56%
Zacks Investment ResearchThu, 02 Apr 2026 16:26:07 GMTHere's Why You Should Add NeuroPace Stock to Your Portfolio NowNPCE+2.56%
Zacks Investment ResearchThu, 02 Apr 2026 14:56:05 GMTWall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High?NPCE+2.56%
